[New experiences with bleomycin].
26 patients all with squamous call carcinoma of the head and neck were treated primarily with Bleomycin (maximal dose 300 mg by i.v. injections of 15 mg every second day). In 10 of the patients a significant regression of the tumor was achieved. In one particular case no histological evidence of tumor could be found. The expected side effects of Bleomycin were observed. Two patients died of heart-lung failure. Histological examinations showed signs of cytostatic pneumopathy.
D001761:Bleomycin / Q000009:adverse effects / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D004341:Drug Evaluation; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans
D001761:Bleomycin
Neue Erfahrungen mit Bleomycin